{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["antioxidants", "carboplatin", "cisplatin", "neurotoxicity", "oxaliplatin", "peripheral neuropathy", "platinum-based drugs"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33092125", "DateCompleted": {"Year": "2021", "Month": "03", "Day": "01"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "10", "Day": "20"}], "Language": ["eng"], "ELocationID": ["7753", "10.3390/ijms21207753"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "21", "Issue": "20", "PubDate": {"Year": "2020", "Month": "Oct", "Day": "20"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Antioxidant Supplementation in the Treatment of Neurotoxicity Induced by Platinum-Based Chemotherapeutics-A Review.", "Abstract": {"AbstractText": ["Cancer represents one of the most pernicious public health problems with a high mortality rate among patients worldwide. Chemotherapy is one of the major therapeutic approaches for the treatment of various malignancies. Platinum-based drugs (cisplatin, oxaliplatin, carboplatin, etc.) are highly effective chemotherapeutic drugs used for the treatment of several types of malignancies, but their application and dosage are limited by their toxic effects on various systems, including neurotoxicity. Simultaneously, researchers have tried to improve the survival rate and quality of life of cancer patients and decrease the toxicity of platinum-containing drugs by combining them with non-chemotherapy-based drugs, dietary supplements and/or antioxidants. Additionally, recent studies have shown that the root cause for the many side effects of platinum chemotherapeutics involves the production of reactive oxygen species (ROS) in naive cells. Therefore, suppression of ROS generation and their inactivation with antioxidants represents an appropriate approach for platinum drug-induced toxicities. The aim of this paper is to present an updated review of the protective effects of different antioxidant agents (vitamins, dietary antioxidants and supplements, medicaments, medicinal plants and their bioactive compounds) against the neurotoxicity induced by platinum-based chemotherapeutics. This review highlights the high potential of plant antioxidants as adjuvant strategies in chemotherapy with platinum drugs."]}, "AuthorList": [{"Identifier": ["0000-0002-2997-9588"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute for Information Technologies Kragujevac, Department of Science, University of Kragujevac, Jovana Cvijica bb, 34000 Kragujevac, Serbia."}], "LastName": "Stankovic", "ForeName": "Jelena S Katanic", "Initials": "JSK"}, {"Identifier": ["0000-0003-4814-8664"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medical Sciences, Department of Physiology, University of Kragujevac, Svetozara Markovica 69, 34000 Kragujevac, Serbia."}], "LastName": "Selakovic", "ForeName": "Dragica", "Initials": "D"}, {"Identifier": ["0000-0003-4113-6804"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Science, Department of Chemistry, University of Kragujevac, Radoja Domanovica 12, 34000 Kragujevac, Serbia."}], "LastName": "Mihailovic", "ForeName": "Vladimir", "Initials": "V"}, {"Identifier": ["0000-0001-7424-8357"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medical Sciences, Department of Physiology, University of Kragujevac, Svetozara Markovica 69, 34000 Kragujevac, Serbia."}], "LastName": "Rosic", "ForeName": "Gvozden", "Initials": "G"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "04ZR38536J", "NameOfSubstance": "Oxaliplatin"}, {"RegistryNumber": "BG3F62OND5", "NameOfSubstance": "Carboplatin"}, {"RegistryNumber": "Q20Q21Q62J", "NameOfSubstance": "Cisplatin"}], "MeshHeadingList": [{"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Carboplatin"}, {"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Cisplatin"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["etiology", "prevention & control"], "DescriptorName": "Neurotoxicity Syndromes"}, {"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Oxaliplatin"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Reactive Oxygen Species"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Galanski M., Jakupec M., Keppler B. Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches. Curr. Med. Chem. 2005;12:2075\u20132094. doi: 10.2174/0929867054637626.", "ArticleIdList": ["10.2174/0929867054637626", "16101495"]}, {"Citation": "Oun R., Moussa Y.E., Wheate N.J. The side effects of platinum-based chemotherapy drugs: A review for chemists. Dalt. Trans. 2018;47:6645\u20136653. doi: 10.1039/C8DT00838H.", "ArticleIdList": ["10.1039/C8DT00838H", "29632935"]}, {"Citation": "Kosmidis C., Sapalidis K., Zarogoulidis P., Sardeli C., Koulouris C., Giannakidis D., Pavlidis E., Katsaounis A., Michalopoulos N., Mantalobas S., et al. Inhaled cisplatin for NSCLC: Facts and results. Int. J. Mol. Sci. 2019;20:2005. doi: 10.3390/ijms20082005.", "ArticleIdList": ["10.3390/ijms20082005", "PMC6514814", "31022839"]}, {"Citation": "Bergamini A., Pisano C., Di Napoli M., Arenare L., Della Pepa C., Tambaro R., Facchini G., Gargiulo P., Rossetti S., Mangili G., et al. Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin. Gynecol. Oncol. 2017;144:72\u201376. doi: 10.1016/j.ygyno.2016.10.023.", "ArticleIdList": ["10.1016/j.ygyno.2016.10.023", "28094039"]}, {"Citation": "Bucher-Johannessen C., Page C.M., Haugen T.B., Wojewodzic M.W., Foss\u00e5 S.D., Grotmol T., Haugnes H.S., Rounge T.B. Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome. Clin. Epigenetics. 2019;11:179. doi: 10.1186/s13148-019-0764-4.", "ArticleIdList": ["10.1186/s13148-019-0764-4", "PMC6892132", "31796056"]}, {"Citation": "Baek D.W., Park J.-Y., Lee S.J., Chae Y.S. Impressive effect of cisplatin monotherapy on a patient with heavily pretreated triple-negative breast cancer with poor performance. Yeungnam Univ. J. Med. 2020;37:230\u2013235. doi: 10.12701/yujm.2019.00423.", "ArticleIdList": ["10.12701/yujm.2019.00423", "PMC7384912", "31962039"]}, {"Citation": "Angeli E., Nguyen T.T., Janin A., Bousquet G. How to make anticancer drugs cross the blood-brain barrier to treat brain metastases. Int. J. Mol. Sci. 2020;21:22. doi: 10.3390/ijms21010022.", "ArticleIdList": ["10.3390/ijms21010022", "PMC6981899", "31861465"]}, {"Citation": "Brown H.K., Schiavone K., Gouin F., Heymann M.F., Heymann D. Biology of Bone Sarcomas and New Therapeutic Developments. Calcif. Tissue Int. 2018;102:174\u2013195. doi: 10.1007/s00223-017-0372-2.", "ArticleIdList": ["10.1007/s00223-017-0372-2", "PMC5805807", "29238848"]}, {"Citation": "Zhang L., Jia S., Ma Y., Li L., Li X., Wang X., Fu X., Ma W., Qin Y., Li W., et al. Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: Interim analysis of a phase 4 study NCT01501149. Oncotarget. 2016;7:55721\u201355731. doi: 10.18632/oncotarget.10124.", "ArticleIdList": ["10.18632/oncotarget.10124", "PMC5342448", "27384676"]}, {"Citation": "Nguyen J., Solimando D.A., Waddell J.A. Carboplatin and Liposomal Doxorubicin for Ovarian Cancer. Hosp. Pharm. 2016;51:442\u2013449. doi: 10.1310/hpj5106-442.", "ArticleIdList": ["10.1310/hpj5106-442", "PMC4911983", "27354744"]}, {"Citation": "Xiang M., Colevas A.D., Holsinger F.C., Le Q.T.X., Beadle B.M. Survival after definitive chemoradiotherapy with concurrent cisplatin or carboplatin for head and neck cancer. JNCCN J. Natl. Compr. Cancer Netw. 2019;17:1065\u20131073. doi: 10.6004/jnccn.2019.7297.", "ArticleIdList": ["10.6004/jnccn.2019.7297", "31487677"]}, {"Citation": "Akamatsu H., Ninomiya K., Kenmotsu H., Morise M., Daga H., Goto Y., Kozuki T., Miura S., Sasaki T., Tamiya A., et al. The Japanese Lung Cancer Society Guideline for Non-Small Cell Lung Cancer, Stage IV. Volume 24. Springer; Singapore: 2019.", "ArticleIdList": ["PMC6545178", "31049758"]}, {"Citation": "Mart\u00edn-Arag\u00f3n T., Serrano J., Bened\u00ed J., Meiri\u00f1o R.M., Garc\u00eda-Alonso P., Calvo F.A. The value of oxaliplatin in the systemic treatment of locally advanced rectal cancer. J. Gastrointest. Oncol. 2018;9:631\u2013640. doi: 10.21037/jgo.2018.06.02.", "ArticleIdList": ["10.21037/jgo.2018.06.02", "PMC6087854", "30151259"]}, {"Citation": "Zhang F., Zhang Y., Jia Z., Wu H., Gu K. Oxaliplatin-Based regimen is superior to cisplatin-Based regimen in tumour remission as first-line chemotherapy for advanced gastric cancer: A meta-analysis. J. Cancer. 2019;10:1923\u20131929. doi: 10.7150/jca.28896.", "ArticleIdList": ["10.7150/jca.28896", "PMC6547983", "31205551"]}, {"Citation": "Bogliolo S., Cassani C., Gardella B., Musacchi V., Babilonti L., Venturini P.-L., Ferrero S., Spinillo A. Oxaliplatin for the treatment of ovarian cancer. Expert Opin. Investig. Drugs. 2015;24:1275\u20131286. doi: 10.1517/13543784.2015.1062874.", "ArticleIdList": ["10.1517/13543784.2015.1062874", "26125301"]}, {"Citation": "Cao S., Wang C., Ma H., Yin R., Zhu M., Shen W., Dai J., Shu Y., Xu L., Hu Z., et al. Genome-wide association study on platinum-induced hepatotoxicity in non-small cell lung cancer patients. Sci. Rep. 2015;5:1\u20138. doi: 10.1038/srep11556.", "ArticleIdList": ["10.1038/srep11556", "PMC4477405", "26100964"]}, {"Citation": "Ai D., Guan Y., Liu X.J., Zhang C.F., Wang P., Liang H.L., Guo Q. Sen Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer. Onco Targets Ther. 2016;9:5693\u20135698. doi: 10.2147/OTT.S109683.", "ArticleIdList": ["10.2147/OTT.S109683", "PMC5033500", "27695347"]}, {"Citation": "Tixier F., Ranchon F., Iltis A., Vantard N., Schwiertz V., Bachy E., Bouafia-Sauvy F., Sarkozy C., Tournamille J.F., Gyan E., et al. Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients. Hematol. Oncol. 2017;35:584\u2013590. doi: 10.1002/hon.2328.", "ArticleIdList": ["10.1002/hon.2328", "27377614"]}, {"Citation": "Kart A., Cigremis Y., Karaman M., Ozen H. Caffeic acid phenethyl ester (CAPE) ameliorates cisplatin-induced hepatotoxicity in rabbit. Exp. Toxicol. Pathol. 2010;62:45\u201352. doi: 10.1016/j.etp.2009.02.066.", "ArticleIdList": ["10.1016/j.etp.2009.02.066", "19268559"]}, {"Citation": "Khan M.W., Zhao P., Khan A., Raza F., Raza S.M., Sarfraz M., Chen Y., Li M., Yang T., Ma X., et al. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity. Int. J. Nanomed. 2019;14:3753\u20133771. doi: 10.2147/IJN.S196651.", "ArticleIdList": ["10.2147/IJN.S196651", "PMC6554709", "31239661"]}, {"Citation": "Eoh K.J., Lee J.Y., Nam E.J., Kim S., Kim Y.T., Kim S.W. Long-term survival analysis of intraperitoneal versus intravenous chemotherapy for primary ovarian cancer and comparison between carboplatin- and cisplatin-based intraperitoneal chemotherapy. J. Korean Med. Sci. 2017;32:2021\u20132028. doi: 10.3346/jkms.2017.32.12.2021.", "ArticleIdList": ["10.3346/jkms.2017.32.12.2021", "PMC5680503", "29115086"]}, {"Citation": "Grigorian A., Brien C.B.O. Hepatotoxicity Secondary to Chemotherapy. J. Clin. Trans. Hepatol. 2014;2:95\u2013102.", "ArticleIdList": ["PMC4521265", "26357620"]}, {"Citation": "Argyriou A.A., Bruna J., Marmiroli P., Cavaletti G. Chemotherapy-induced peripheral neurotoxicity (CIPN): An update. Crit. Rev. Oncol. Hematol. 2012;82:51\u201377. doi: 10.1016/j.critrevonc.2011.04.012.", "ArticleIdList": ["10.1016/j.critrevonc.2011.04.012", "21908200"]}, {"Citation": "Karavelioglu E., Boyaci M.G., Simsek N., Sonmez M.A., Koc R., Karademir M., Guven M., Eser O. Selenium protects cerebral cells by cisplatin induced neurotoxicity. Acta Cir. Bras. 2015;30:394\u2013400. doi: 10.1590/S0102-865020150060000004.", "ArticleIdList": ["10.1590/S0102-865020150060000004", "26108027"]}, {"Citation": "Salman M., Naseem I., Hassan I., Khan A.A., Alhazza I.M. Riboflavin arrests cisplatin-induced neurotoxicity by ameliorating cellular damage in dorsal root ganglion cells. Biomed Res. Int. 2015;2015 doi: 10.1155/2015/603543.", "ArticleIdList": ["10.1155/2015/603543", "PMC4681007", "26759811"]}, {"Citation": "McDonald E.S., Randon K.R., Knight A., Windebank A.J. Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: A potential mechanism for neurotoxicity. Neurobiol. Dis. 2005;18:305\u2013313. doi: 10.1016/j.nbd.2004.09.013.", "ArticleIdList": ["10.1016/j.nbd.2004.09.013", "15686959"]}, {"Citation": "Podratz J.L., Knight A.M., Ta L.E., Staff N.P., Gass J.M., Genelin K., Schlattau A., Lathroum L., Windebank A.J. Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons. Neurobiol. Dis. 2011;41:661\u2013668. doi: 10.1016/j.nbd.2010.11.017.", "ArticleIdList": ["10.1016/j.nbd.2010.11.017", "PMC3031677", "21145397"]}, {"Citation": "Leo M., Schmitt L.I., Erkel M., Melnikova M., Thomale J., Hagenacker T. Cisplatin-induced neuropathic pain is mediated by upregulation of N-type voltage-gated calcium channels in dorsal root ganglion neurons. Exp. Neurol. 2017;288:62\u201374. doi: 10.1016/j.expneurol.2016.11.003.", "ArticleIdList": ["10.1016/j.expneurol.2016.11.003", "27823926"]}, {"Citation": "Zhao M., Isami K., Nakamura S., Shirakawa H., Nakagawa T., Kaneko S. Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice. Mol. Pain. 2012;8:1\u201311. doi: 10.1186/1744-8069-8-55.", "ArticleIdList": ["10.1186/1744-8069-8-55", "PMC3495669", "22839205"]}, {"Citation": "Dietrich J., Han R., Yang Y., Mayer-Pr\u00f6schel M., Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J. Biol. 2006;5 doi: 10.1186/jbiol50.", "ArticleIdList": ["10.1186/jbiol50", "PMC2000477", "17125495"]}, {"Citation": "Pantic M., Minic M. The Evaluation of the Effects of N-Acetylcysteine on Cisplatin-Induced Alterations in Exploratory Activity in Elevated Plus Maze Test in Rats. Serbian J. Exp. Clin. Res. 2019;20:65\u201372. doi: 10.1515/sjecr-2017-0053.", "ArticleIdList": ["10.1515/sjecr-2017-0053"]}, {"Citation": "Abdelkader N.F., Saad M.A., Abdelsalam R.M. Neuroprotective effect of nebivolol against cisplatin-associated depressive-like behavior in rats. J. Neurochem. 2017;141:449\u2013460. doi: 10.1111/jnc.13978.", "ArticleIdList": ["10.1111/jnc.13978", "28178754"]}, {"Citation": "Lomeli N., Di K., Czerniawski J., Guzowski J.F., Bota D.A. Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats. Free Radic. Biol. Med. 2017;102:274\u2013286. doi: 10.1016/j.freeradbiomed.2016.11.046.", "ArticleIdList": ["10.1016/j.freeradbiomed.2016.11.046", "PMC5308450", "27908784"]}, {"Citation": "Chiu G.S., Maj M.A., Rizvi S., Dantzer R., Vichaya E.G., Laumet G., Kavelaars A., Heijnen C.J. Pifithrin-m prevents cisplatin-induced chemobrain by preserving neuronal mitochondrial function. Cancer Res. 2017;77:742\u2013752. doi: 10.1158/0008-5472.CAN-16-1817.", "ArticleIdList": ["10.1158/0008-5472.CAN-16-1817", "PMC5290207", "27879267"]}, {"Citation": "Neha K., Haider M.R., Pathak A., Yar M.S. Medicinal prospects of antioxidants: A review. Eur. J. Med. Chem. 2019;178:687\u2013704. doi: 10.1016/j.ejmech.2019.06.010.", "ArticleIdList": ["10.1016/j.ejmech.2019.06.010", "31228811"]}, {"Citation": "Carocho M., Morales P., Ferreira I.C.F.R. Antioxidants: Reviewing the chemistry, food applications, legislation and role as preservatives. Trends Food Sci. Technol. 2018;71:107\u2013120. doi: 10.1016/j.tifs.2017.11.008.", "ArticleIdList": ["10.1016/j.tifs.2017.11.008"]}, {"Citation": "Amr M. In: Antioxidant Enzyme. El-Missiry M.A., editor. InTechOpen Limited; London, UK: 2012."}, {"Citation": "Carocho M., Ferreira I.C.F.R. A review on antioxidants, prooxidants and related controversy: Natural and synthetic compounds, screening and analysis methodologies and future perspectives. Food Chem. Toxicol. 2013;51:15\u201325. doi: 10.1016/j.fct.2012.09.021.", "ArticleIdList": ["10.1016/j.fct.2012.09.021", "23017782"]}, {"Citation": "Warraich U.E.A., Hussain F., Kayani H.U.R. Aging - Oxidative stress, antioxidants and computational modeling. Heliyon. 2020;6:e04107. doi: 10.1016/j.heliyon.2020.e04107.", "ArticleIdList": ["10.1016/j.heliyon.2020.e04107", "PMC7264715", "32509998"]}, {"Citation": "Ighodaro O.M., Akinloye O.A. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alex. J. Med. 2018;54:287\u2013293. doi: 10.1016/j.ajme.2017.09.001.", "ArticleIdList": ["10.1016/j.ajme.2017.09.001"]}, {"Citation": "Niki E. Advances in DNA Damage and Repair. Springer US; Boston, MA, USA: 1999. Antioxidant defenses in eukaryotic cells; pp. 313\u2013318."}, {"Citation": "Miro\u0144czuk-Chodakowska I., Witkowska A.M., Zujko M.E. Endogenous non-enzymatic antioxidants in the human body. Adv. Med. Sci. 2018;63:68\u201378. doi: 10.1016/j.advms.2017.05.005.", "ArticleIdList": ["10.1016/j.advms.2017.05.005", "28822266"]}, {"Citation": "Harris I.S., DeNicola G.M. The Complex Interplay between Antioxidants and ROS in Cancer. Trends Cell Biol. 2020;30:440\u2013451. doi: 10.1016/j.tcb.2020.03.002.", "ArticleIdList": ["10.1016/j.tcb.2020.03.002", "32303435"]}, {"Citation": "Lobo V., Patil A., Phatak A., Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn. Rev. 2010;4:118\u2013126. doi: 10.4103/0973-7847.70902.", "ArticleIdList": ["10.4103/0973-7847.70902", "PMC3249911", "22228951"]}, {"Citation": "Olszowy M. What is responsible for antioxidant properties of polyphenolic compounds from plants? Plant Physiol. Biochem. 2019;144:135\u2013143. doi: 10.1016/j.plaphy.2019.09.039.", "ArticleIdList": ["10.1016/j.plaphy.2019.09.039", "31563754"]}, {"Citation": "Diet, Nutrition and the Prevention of Chronic Diseases. World Health Organization; Geneva, Switzerland: 2003. 149p (World Health Organization Technical Report Series 916).", "ArticleIdList": ["12768890"]}, {"Citation": "Watson R.R., Zibadi S. Nutritional Modulators of Pain in the Aging Population. Nutr. Modul. Pain Aging Popul. 2017:1\u2013298. doi: 10.1016/B978-0-12-805186-3/00026-6.", "ArticleIdList": ["10.1016/B978-0-12-805186-3/00026-6"]}, {"Citation": "Pellacani C., Eleftheriou G. Neurotoxicity of antineoplastic drugs: Mechanisms, susceptibility, and neuroprotective strategies. Adv. Med. Sci. 2020;65:265\u2013285. doi: 10.1016/j.advms.2020.04.001.", "ArticleIdList": ["10.1016/j.advms.2020.04.001", "32361484"]}, {"Citation": "Erken H.A., Ko\u00e7 E.R., Yazici H., Yay A., \u00d6nder G.\u00d6., Sarici S.F. Selenium partially prevents cisplatin-induced neurotoxicity: A preliminary study. Neurotoxicology. 2014;42:71\u201375. doi: 10.1016/j.neuro.2014.04.002.", "ArticleIdList": ["10.1016/j.neuro.2014.04.002", "24751598"]}, {"Citation": "Tredici G., Tredici S., Fabbrica D., Minoia C., Cavaletti G. Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration. J. Neurooncol. 1998;36:31\u201340. doi: 10.1023/A:1005756023082.", "ArticleIdList": ["10.1023/A:1005756023082", "9525823"]}, {"Citation": "Arrieta O., Hern\u00e1ndez-Pedro N., Fern\u00e1ndez-Gonz\u00e1lez-Arag\u00f3n M.C., Saavedra-P\u00e9rez D., Campos-Parra A.D., R\u00edos-Trejo M.A., Cer\u00f3n-Liz\u00e1rraga T., Mart\u00ednez-Barrera L., Pineda B., Ord\u00f3\u00f1ez G., et al. Retinoic acid reduces chemotherapy-induced neuropathy in an animal model and patients with lung cancer. Neurology. 2011;77:987\u2013995. doi: 10.1212/WNL.0b013e31822e045c.", "ArticleIdList": ["10.1212/WNL.0b013e31822e045c", "PMC3171957", "21865574"]}, {"Citation": "Leonetti C., Biroccio A., Gabellini C., Scarsella M., Maresca V., Flori E., Bove L., Pace A., Stopacciaro A., Zupi G., et al. \u03b1-Tocopherol Protects Against Cisplatin-Induced Toxicity Without Interfering With Antitumor Efficacy. Int. J. Cancer. 2003;104:243\u2013250. doi: 10.1002/ijc.10933.", "ArticleIdList": ["10.1002/ijc.10933", "12569582"]}, {"Citation": "Argyriou A.A., Chroni E., Koutras A., Iconomou G., Papapetropoulos S., Polychronopoulos P., Kalofonos H.P. A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: Final results. Support. Care Cancer. 2006;14:1134\u20131140. doi: 10.1007/s00520-006-0072-3.", "ArticleIdList": ["10.1007/s00520-006-0072-3", "16622646"]}, {"Citation": "Pace A., Giannarelli D., Gali\u00e8 E., Savarese A., Carpano S., Della Giulia M., Pozzi A., Silvani A., Gaviani P., Scaioli V., et al. Vitamin e neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial. Neurology. 2010;74:762\u2013766. doi: 10.1212/WNL.0b013e3181d5279e.", "ArticleIdList": ["10.1212/WNL.0b013e3181d5279e", "20194916"]}, {"Citation": "Kottschade L.A., Sloan J.A., Mazurczak M.A., Johnson D.B., Murphy B.P., Rowland K.M., Smith D.A., Berg A.R., Stella P.J., Loprinzi C.L. The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: Results of a randomized phase III clinical trial. Support. Care Cancer. 2011;19:1769\u20131777. doi: 10.1007/s00520-010-1018-3.", "ArticleIdList": ["10.1007/s00520-010-1018-3", "PMC3329941", "20936417"]}, {"Citation": "Afonseca S.O.D., Cruz F.M., Cubero D.D.I.G., Lera A.T., Schindler F., Okawara M., Souza L.F.D., Rodrigues N.P., Giglio A.D. Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial. Sao Paulo Med. J. 2013;131:35\u201338. doi: 10.1590/S1516-31802013000100006.", "ArticleIdList": ["10.1590/S1516-31802013000100006", "PMC10852076", "23538593"]}, {"Citation": "Salehi Z., Roayaei M. Effect of Vitamin E on oxaliplatin-induced peripheral neuropathy prevention: A randomized controlled trial. Int. J. Prev. Med. 2015;6:104. doi: 10.4103/2008-7802.169021.", "ArticleIdList": ["10.4103/2008-7802.169021", "PMC4671163", "26682028"]}, {"Citation": "Da Silva Machado C., Mendon\u00e7a L.M., Venancio V.D.P., Bianchi M.L.P., Antunes L.M.G. Coenzyme Q10 protects Pc12 cells from cisplatin-induced DNA damage and neurotoxicity. Neurotoxicology. 2013;36:10\u201316. doi: 10.1016/j.neuro.2013.02.004.", "ArticleIdList": ["10.1016/j.neuro.2013.02.004", "23434506"]}, {"Citation": "Turan M.I., Cayir A., Cetin N., Suleyman H., Turan I.S., Tan H. An investigation of the effect of thiamine pyrophosphate on cisplatin-induced oxidative stress and DNA damage in rat brain tissue compared with thiamine: Thiamine and thiamine pyrophosphate effects on cisplatin neurotoxicity. Hum. Exp. Toxicol. 2014;33:14\u201321. doi: 10.1177/0960327113485251.", "ArticleIdList": ["10.1177/0960327113485251", "23632005"]}, {"Citation": "Takeshita M., Banno Y., Nakamura M., Otsuka M., Teramachi H., Tsuchiya T., Itoh Y. The Pivotal Role of Intracellular Calcium in Oxaliplatin-Induced Inhibition of Neurite Outgrowth but Not Cell Death in Differentiated PC12 Cells. Chem. Res. Toxicol. 2011;24:1845\u20131852. doi: 10.1021/tx200160g.", "ArticleIdList": ["10.1021/tx200160g", "21981408"]}, {"Citation": "Sakurai M., Egashira N., Kawashiri T., Yano T., Ikesue H., Oishi R. Oxaliplatin-induced neuropathy in the rat: Involvement of oxalate in cold hyperalgesia but not mechanical allodynia. Pain. 2009;147:165\u2013174. doi: 10.1016/j.pain.2009.09.003.", "ArticleIdList": ["10.1016/j.pain.2009.09.003", "19782472"]}, {"Citation": "Loprinzi C.L., Qin R., Dakhil S.R., Fehrenbacher L., Flynn K.A., Atherton P., Seisler D., Qamar R., Lewis G.C., Grothey A. Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance) J. Clin. Oncol. 2014;32:997\u20131005. doi: 10.1200/JCO.2013.52.0536.", "ArticleIdList": ["10.1200/JCO.2013.52.0536", "PMC3965262", "24297951"]}, {"Citation": "Melli G., Taiana M., Camozzi F., Triolo D., Podini P., Quattrini A., Taroni F., Lauria G. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Exp. Neurol. 2008;214:276\u2013284. doi: 10.1016/j.expneurol.2008.08.013.", "ArticleIdList": ["10.1016/j.expneurol.2008.08.013", "18809400"]}, {"Citation": "Tuncer S., Dalkilic N., Akif Dunbar M., Keles B. Comparative effects of alpha lipoic acid and melatonin on cisplatin-induced neurotoxicity. Int. J. Neurosci. 2010;120:655\u2013663. doi: 10.3109/00207454.2010.510916.", "ArticleIdList": ["10.3109/00207454.2010.510916", "20942579"]}, {"Citation": "Guo Y., Jones D., Palmer J.L., Forman A., Dakhil S.R., Velasco M.R., Weiss M., Gilman P., Mills G.M., Noga S.J., et al. Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: A randomized, double-blind, placebo-controlled trial. Support. Care Cancer. 2014;22:1223\u20131231. doi: 10.1007/s00520-013-2075-1.", "ArticleIdList": ["10.1007/s00520-013-2075-1", "PMC5924730", "24362907"]}, {"Citation": "Gedlicka C., Scheithauer W., Schull B., Kornek G.V. Effective Treatment of Oxaliplatin-Induced Cumulative Polyneuropathy With Alpha-Lipoic Acid. J. Clin. Oncol. 2002;20:3356\u20133357. doi: 10.1200/JCO.2002.99.502.", "ArticleIdList": ["10.1200/JCO.2002.99.502", "12149316"]}, {"Citation": "Gedlicka C., Kornek G.V., Schmid K., Scheithauer W. Amelioration of docetaxel/cisplatin induced polyneuropathy by \u03b1-lipoic acid. Ann. Oncol. 2003;14:339\u2013340. doi: 10.1093/annonc/mdg051.", "ArticleIdList": ["10.1093/annonc/mdg051", "12562664"]}, {"Citation": "Yehia R., Saleh S., El Abhar H., Saad A.S., Schaalan M. L-Carnosine protects against Oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: A perspective on targeting Nrf-2 and NF-\u03baB pathways. Toxicol. Appl. Pharmacol. 2019;365:41\u201350. doi: 10.1016/j.taap.2018.12.015.", "ArticleIdList": ["10.1016/j.taap.2018.12.015", "30592963"]}, {"Citation": "Song T.Y., Chen C.L., Liao J.W., Ou H.C., Tsai M.S. Ergothioneine protects against neuronal injury induced by cisplatin both in vitro and in vivo. Food Chem. Toxicol. 2010;48:3492\u20133499. doi: 10.1016/j.fct.2010.09.030.", "ArticleIdList": ["10.1016/j.fct.2010.09.030", "20932872"]}, {"Citation": "Zhu J., Carozzi V.A., Reed N., Mi R., Marmiroli P., Cavaletti G., Hoke A. Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity. Sci. Rep. 2016;6:1\u201310. doi: 10.1038/srep28861.", "ArticleIdList": ["10.1038/srep28861", "PMC4924091", "27350330"]}, {"Citation": "Waseem M., Tabassum H., Parvez S. Neuroprotective effects of melatonin as evidenced by abrogation of oxaliplatin induced behavioral alterations, mitochondrial dysfunction and neurotoxicity in rat brain. Mitochondrion. 2016;30:168\u2013176. doi: 10.1016/j.mito.2016.08.001.", "ArticleIdList": ["10.1016/j.mito.2016.08.001", "27497633"]}, {"Citation": "Gopal K.V., Wu C., Shrestha B., Campbell K.C.M., Moore E.J., Gross G.W. D-Methionine protects against cisplatin-induced neurotoxicity in cortical networks. Neurotoxicol. Teratol. 2012;34:495\u2013504. doi: 10.1016/j.ntt.2012.06.002.", "ArticleIdList": ["10.1016/j.ntt.2012.06.002", "22732230"]}, {"Citation": "Hinduja S., Kraus K.S., Manohar S., Salvi R.J. D-Methionine Protects Against Cisplatin-Induced Neurotoxicity in the Hippocampus of the Adult Rat. Neurotox. Res. 2015;27:199\u2013204. doi: 10.1007/s12640-014-9503-y.", "ArticleIdList": ["10.1007/s12640-014-9503-y", "PMC4376112", "25488710"]}, {"Citation": "Rosic G., Joksimovic J., Selakovic D., Jakovljevic V., Zivkovic V., Srejovic I., Djuric M., Djuric D. The Beneficial Effects of Sulfur-containing Amino Acids on Cisplatin-induced Cardiotoxicity and Neurotoxicity in Rodents. Curr. Med. Chem. 2017;24:1\u201313. doi: 10.2174/0929867324666170705114456.", "ArticleIdList": ["10.2174/0929867324666170705114456", "28685675"]}, {"Citation": "Owoeye O., Adedara I.A., Farombi E.O. Pretreatment with taurine prevented brain injury and exploratory behaviour associated with administration of anticancer drug cisplatin in rats. Biomed. Pharmacother. 2018;102:375\u2013384. doi: 10.1016/j.biopha.2018.03.051.", "ArticleIdList": ["10.1016/j.biopha.2018.03.051", "29571023"]}, {"Citation": "Fu X., Wu H., Li J., Wang C., Li M., Ma Q., Yang W. Efficacy of drug interventions for chemotherapy-induced chronic peripheral neurotoxicity: A network meta-analysis. Front. Neurol. 2017;8:4\u20136. doi: 10.3389/fneur.2017.00223.", "ArticleIdList": ["10.3389/fneur.2017.00223", "PMC5462987", "28642731"]}, {"Citation": "Martinez N.W., S\u00e1nchez A., Diaz P., Broekhuizen R., Godoy J., Mondaca S., Catenaccio A., Macanas P., Nervi B., Calvo M., et al. Metformin protects from oxaliplatin induced peripheral neuropathy in rats. Neurobiol. Pain. 2020;8:100048. doi: 10.1016/j.ynpai.2020.100048.", "ArticleIdList": ["10.1016/j.ynpai.2020.100048", "PMC7260677", "32490289"]}, {"Citation": "Kawashiri T., Miyagi A., Shimizu S., Shigematsu N., Kobayashi D., Shimazoe T. Dimethyl fumarate ameliorates chemotherapy agent-induced neurotoxicity in vitro. J. Pharmacol. Sci. 2018;137:202\u2013211. doi: 10.1016/j.jphs.2018.06.008.", "ArticleIdList": ["10.1016/j.jphs.2018.06.008", "30042024"]}, {"Citation": "Areti A., Komirishetty P., Kumar A. Carvedilol prevents functional deficits in peripheral nerve mitochondria of rats with oxaliplatin-evoked painful peripheral neuropathy. Toxicol. Appl. Pharmacol. 2017;322:97\u2013103. doi: 10.1016/j.taap.2017.03.009.", "ArticleIdList": ["10.1016/j.taap.2017.03.009", "28286117"]}, {"Citation": "Akman T., Akman L., Erbas O., Terek M.C., Taskiran D., Ozsaran A. The preventive effect of oxytocin to cisplatin-induced neurotoxicity: An experimental rat model. BioMed Res. Int. 2015;2015:13\u201317. doi: 10.1155/2015/167235.", "ArticleIdList": ["10.1155/2015/167235", "PMC4320931", "25688351"]}, {"Citation": "Kim S.T., Chung Y.H., Lee H.S., Chung S.J., Lee J.H., Sohn U.D., Shin Y.K., Park E.S., Kim H.C., Bang J.S., et al. Protective effects of phosphatidylcholine on oxaliplatin-induced neuropathy in rats. Life Sci. 2015;130:81\u201387. doi: 10.1016/j.lfs.2015.03.013.", "ArticleIdList": ["10.1016/j.lfs.2015.03.013", "25817232"]}, {"Citation": "Chen X.F., Wang R., Yin Y.M., R\u00f8e O.D., Li J., Zhu L.J., Guo R.H., Wu T., Shu Y.Q. The effect of monosialotetrahexosylganglioside (GM1) in prevention of oxaliplatin induced neurotoxicity: A retrospective study. Biomed. Pharmacother. 2012;66:279\u2013284. doi: 10.1016/j.biopha.2012.01.002.", "ArticleIdList": ["10.1016/j.biopha.2012.01.002", "22397758"]}, {"Citation": "Vukovic R., Kumburovic I., Joksimovic Jovic J., Jovicic N., Katanic Stankovic J.S., Mihailovic V., Djuric M., Velickovic S., Arnaut A., Selakovic D., et al. N-acetylcysteine protects against the anxiogenic response to cisplatin in rats. Biomolecules. 2019;9:892. doi: 10.3390/biom9120892.", "ArticleIdList": ["10.3390/biom9120892", "PMC6995611", "31861240"]}, {"Citation": "McQuade R.M., Stojanovska V., Bornstein J.C., Nurgali K. PARP inhibition in platinum-based chemotherapy: Chemopotentiation and neuroprotection. Pharmacol. Res. 2018;137:104\u2013113. doi: 10.1016/j.phrs.2018.09.031.", "ArticleIdList": ["10.1016/j.phrs.2018.09.031", "30278221"]}, {"Citation": "Parker A.R., Petluru P.N., Nienaber V.L., Zhao M., Ayala P.Y., Badger J., Chie-Leon B., Sridhar V., Logan C., Kochat H., et al. Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787. Onco Targets Ther. 2015;8:375\u2013383. doi: 10.2147/OTT.S73690.", "ArticleIdList": ["10.2147/OTT.S73690", "PMC4324543", "25678804"]}, {"Citation": "Hausheer F.H., Shanmugarajah D., Leverett B.D., Chen X., Huang Q., Kochat H., Petluru P.N., Parker A.R. Mechanistic study of BNP7787-mediated cisplatin nephroprotection: Modulation of gamma-glutamyl transpeptidase. Cancer Chemother. Pharmacol. 2010;65:941\u2013951. doi: 10.1007/s00280-009-1101-y.", "ArticleIdList": ["10.1007/s00280-009-1101-y", "19714332"]}, {"Citation": "Gandara D.R., Nahhas W.A., Adelson M.D., Lichtman S.M., Podczaski E.S., Yanovich S., Homesley H.D., Braly P., Ritch P.S., Weisberg S.R., et al. Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities. J. Clin. Oncol. 1995;13:490\u2013496. doi: 10.1200/JCO.1995.13.2.490.", "ArticleIdList": ["10.1200/JCO.1995.13.2.490", "7844610"]}, {"Citation": "Stehr J.E., Lundstr\u00f6m I., Karlsson J.O.G. Evidence that fodipir (DPDP) binds neurotoxic Pt2+ with a high affinity: An electron paramagnetic resonance study. Sci. Rep. 2019;9:1\u20139. doi: 10.1038/s41598-019-52248-9.", "ArticleIdList": ["10.1038/s41598-019-52248-9", "PMC6825159", "31676855"]}, {"Citation": "Coriat R., Alexandre J., Nicco C., Quinquis L., Benoit E., Ch\u00e9reau C., Lemar\u00e9chal H., Mir O., Borderie D., Tr\u00e9luyer J.M., et al. Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir. J. Clin. Investig. 2014;124:262\u2013272. doi: 10.1172/JCI68730.", "ArticleIdList": ["10.1172/JCI68730", "PMC3871222", "24355920"]}, {"Citation": "Karlsson J.-O., Reineke K., Kurz T., Andersson R., Hall M., McLaughlin C., Jacobsson S., Nasstrom J. Calmangafodipir, A New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment. Application No. 14/922,555. U.S. Patent. 2015 Oct 26;"}, {"Citation": "Cassidy J., Bjarnason G.A., Hickish T., Topham C., Provencio M., Bodoky G., Landherr L., Koralewski P., Lopez-Vivanco G., Said G. Randomized double blind (DB) placebo (Plcb) controlled phase III study assessing the efficacy of xaliproden (X) in reducing the cumulative peripheral sensory neuropathy (PSN) induced by the oxaliplatin (Ox) and 5-FU/LV combination (FOLFOX4) in first-line. J. Clin. Oncol. 2006;24:3507. doi: 10.1200/jco.2006.24.18_suppl.3507.", "ArticleIdList": ["10.1200/jco.2006.24.18_suppl.3507"]}, {"Citation": "Gao L., Zheng Y., Zhao C., Teng H. Investigation on effect of basalin coated silver nanoparticles as antioxidant for alleviating peripheral neuropathy in mice treated with oxaliplatin. J. Photochem. Photobiol. B Biol. 2017;177:56\u201361. doi: 10.1016/j.jphotobiol.2017.10.003.", "ArticleIdList": ["10.1016/j.jphotobiol.2017.10.003", "29069632"]}, {"Citation": "Pr\u0161a P., Karademir B., Bi\u00e7im G., Mahmoud H., Dahan I., Yal\u00e7\u0131n A.S., Mahajna J., Milisav I. The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics. Biochem. Pharmacol. 2020;173:113551. doi: 10.1016/j.bcp.2019.06.007.", "ArticleIdList": ["10.1016/j.bcp.2019.06.007", "31185225"]}, {"Citation": "Brami C., Bao T., Deng G. Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review. Crit. Rev. Oncol. Hematol. 2016;98:325\u2013334. doi: 10.1016/j.critrevonc.2015.11.014.", "ArticleIdList": ["10.1016/j.critrevonc.2015.11.014", "PMC4727999", "26652982"]}, {"Citation": "Gamelin L. Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions: A Retrospective Study of 161 Patients Receiving Oxaliplatin Combined with 5-Fluorouracil and Leucovorin for Advanced Colorectal Cancer. Clin. Cancer Res. 2004;10:4055\u20134061. doi: 10.1158/1078-0432.CCR-03-0666.", "ArticleIdList": ["10.1158/1078-0432.CCR-03-0666", "15217938"]}, {"Citation": "Calls A., Carozzi V., Navarro X., Monza L., Bruna J. Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies. Exp. Neurol. 2020;325:113141. doi: 10.1016/j.expneurol.2019.113141.", "ArticleIdList": ["10.1016/j.expneurol.2019.113141", "31865195"]}, {"Citation": "Amptoulach S., Tsavaris N. Neurotoxicity Caused by the Treatment with Platinum Analogues. Chemother. Res. Pract. 2011;2011:1\u20135. doi: 10.1155/2011/843019.", "ArticleIdList": ["10.1155/2011/843019", "PMC3265255", "22312559"]}, {"Citation": "Kouvaris J.R., Kouloulias V.E., Vlahos L.J. Amifostine: The First Selective-Target and Broad-Spectrum Radioprotector. Oncologist. 2007;12:738\u2013747. doi: 10.1634/theoncologist.12-6-738.", "ArticleIdList": ["10.1634/theoncologist.12-6-738", "17602063"]}, {"Citation": "Avan A., Postma T.J., Ceresa C., Avan A., Cavaletti G., Giovannetti E., Peters G.J. Platinum-Induced Neurotoxicity and Preventive Strategies: Past, Present, and Future. Oncologist. 2015;20:411\u2013432. doi: 10.1634/theoncologist.2014-0044.", "ArticleIdList": ["10.1634/theoncologist.2014-0044", "PMC4391771", "25765877"]}, {"Citation": "Jordan B., Margulies A., Cardoso F., Cavaletti G., Haugnes H.S., Jahn P., Le Rhun E., Preusser M., Scott\u00e9 F., Taphoorn M.J.B., et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO\u2013EONS\u2013EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann. Oncol. 2020;31 doi: 10.1016/j.annonc.2020.07.003.", "ArticleIdList": ["10.1016/j.annonc.2020.07.003", "32739407"]}, {"Citation": "Andersen O. Chelation Treatment during Acute and Chronic Metal Overexposures-Experimental and Clinical Studies. Elsevier Inc.; Amsterdam, The Netherlands: 2016."}, {"Citation": "Karlsson J.O.G., Andersson R.G., Jynge P. Mangafodipir a Selective Cytoprotectant\u2014With Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN) Transl. Oncol. 2017;10:641\u2013649. doi: 10.1016/j.tranon.2017.04.012.", "ArticleIdList": ["10.1016/j.tranon.2017.04.012", "PMC5496205", "28668762"]}, {"Citation": "Glimelius B., Manojlovic N., Pfeiffer P., Mosidze B., Kurteva G., Karlberg M., Mahalingam D., Buhl Jensen P., Kowalski J., Bengtson M., et al. Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx\u00ae): A placebo-controlled randomised phase II study (PLIANT) Acta Oncol. (Madr.) 2018;57:393\u2013402. doi: 10.1080/0284186X.2017.1398836.", "ArticleIdList": ["10.1080/0284186X.2017.1398836", "29140155"]}, {"Citation": "Karlsson J.O.G., Jynge P. Is it possible to draw firm conclusions from the PLIANT trial? Acta Oncol. (Madr.) 2018;57:862\u2013864. doi: 10.1080/0284186X.2017.1416167.", "ArticleIdList": ["10.1080/0284186X.2017.1416167", "29243552"]}, {"Citation": "Newman D.J., Cragg G.M. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J. Nat. Prod. 2020;83:770\u2013803. doi: 10.1021/acs.jnatprod.9b01285.", "ArticleIdList": ["10.1021/acs.jnatprod.9b01285", "32162523"]}, {"Citation": "Shahidi F., Ambigaipalan P. Phenolics and polyphenolics in foods, beverages and spices: Antioxidant activity and health effects\u2014A review. J. Funct. Foods. 2015;18:820\u2013897. doi: 10.1016/j.jff.2015.06.018.", "ArticleIdList": ["10.1016/j.jff.2015.06.018"]}, {"Citation": "Li W., Guo Y., Zhang C., Wu R., Yang A.Y., Gaspar J., Kong A.-N.T. Dietary Phytochemicals and Cancer Chemoprevention: A Perspective on Oxidative Stress, Inflammation, and Epigenetics. Chem. Res. Toxicol. 2016;29:2071\u20132095. doi: 10.1021/acs.chemrestox.6b00413.", "ArticleIdList": ["10.1021/acs.chemrestox.6b00413", "27989132"]}, {"Citation": "Sak K. Chemotherapy and dietary phytochemical agents. Chemother. Res. Pract. 2012;2012:282570. doi: 10.1155/2012/282570.", "ArticleIdList": ["10.1155/2012/282570", "PMC3539428", "23320169"]}, {"Citation": "Pan M.-H., Lai C.-S., Ho C.-T. Anti-inflammatory activity of natural dietary flavonoids. Food Funct. 2010;1:15\u201331. doi: 10.1039/c0fo00103a.", "ArticleIdList": ["10.1039/c0fo00103a", "21776454"]}, {"Citation": "Mendon\u00e7a L.M., da Silva Machado C., Correia Teixeira C.C., Pedro de Freitas L.A., Pires Bianchi M.D.L., Greggi Antunes L.M. Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells. Neurotoxicology. 2013;34:205\u2013211. doi: 10.1016/j.neuro.2012.09.011.", "ArticleIdList": ["10.1016/j.neuro.2012.09.011", "23036615"]}, {"Citation": "Oz M., Nurullahoglu Atalik K.E., Yerlikaya F.H., Demir E.A. Curcumin alleviates cisplatin-induced learning and memory impairments. Neurobiol. Learn. Mem. 2015;123:43\u201349. doi: 10.1016/j.nlm.2015.05.001.", "ArticleIdList": ["10.1016/j.nlm.2015.05.001", "25982942"]}, {"Citation": "Waseem M., Parvez S. Neuroprotective activities of curcumin and quercetin with potential relevance to mitochondrial dysfunction induced by oxaliplatin. Protoplasma. 2016;253:417\u2013430. doi: 10.1007/s00709-015-0821-6.", "ArticleIdList": ["10.1007/s00709-015-0821-6", "26022087"]}, {"Citation": "Al Moundhri M.S., Al-Salam S., Al Mahrouqee A., Beegam S., Ali B.H. The Effect of Curcumin on Oxaliplatin and Cisplatin Neurotoxicity in Rats: Some Behavioral, Biochemical, and Histopathological Studies. J. Med. Toxicol. 2013;9:25\u201333. doi: 10.1007/s13181-012-0239-x.", "ArticleIdList": ["10.1007/s13181-012-0239-x", "PMC3576489", "22648527"]}, {"Citation": "Azevedo M.I., Pereira A.F., Nogueira R.B., Rolim F.E., Brito G.A.C., Wong D.V.T., Lima-J\u00fanior R.C.P., de Albuquerque Ribeiro R., Vale M.L. The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy. Mol. Pain. 2013;9:1\u201314. doi: 10.1186/1744-8069-9-53.", "ArticleIdList": ["10.1186/1744-8069-9-53", "PMC3835704", "24152430"]}, {"Citation": "Almutairi M.M., Alanazi W.A., Alshammari M.A., Alotaibi M.R., Alhoshani A.R., Al-Rejaie S.S., Hafez M.M., Al-Shabanah O.A. Neuro-protective effect of rutin against Cisplatin-induced neurotoxic rat model. BMC Complement. Altern. Med. 2017;17:1\u20139. doi: 10.1186/s12906-017-1976-9.", "ArticleIdList": ["10.1186/s12906-017-1976-9", "PMC5622464", "28962559"]}, {"Citation": "Shahid M., Subhan F., Ahmad N., Sewell R.D.E. The flavonoid 6-methoxyflavone allays cisplatin-induced neuropathic allodynia and hypoalgesia. Biomed. Pharmacother. 2017;95:1725\u20131733. doi: 10.1016/j.biopha.2017.09.108.", "ArticleIdList": ["10.1016/j.biopha.2017.09.108", "28962077"]}, {"Citation": "Cetin D., Hac\u0131muftuoglu A., Tatar A., Turkez H., Togar B. The in vitro protective effect of salicylic acid against paclitaxel and cisplatin-induced neurotoxicity. Cytotechnology. 2016;68:1361\u20131367. doi: 10.1007/s10616-015-9896-3.", "ArticleIdList": ["10.1007/s10616-015-9896-3", "PMC4960183", "26199062"]}, {"Citation": "\u00d6zyurt B., G\u00fcle\u00e7 M., \u00d6zyurt H., Ekici F., At\u0131\u015f \u00d6., Akba\u015f A. The effect of antioxidant caffeic acid phenethyl ester (CAPE) on some enzyme activities in cisplatin-induced neurotoxicity in rats. Eur. J. Gen. Med. 2006;3:167\u2013172. doi: 10.29333/ejgm/82401.", "ArticleIdList": ["10.29333/ejgm/82401"]}, {"Citation": "Areti A., Komirishetty P., Kalvala A.K., Nellaiappan K., Kumar A. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy. Mol. Neurobiol. 2018;55:7463\u20137475. doi: 10.1007/s12035-018-0920-4.", "ArticleIdList": ["10.1007/s12035-018-0920-4", "29427084"]}, {"Citation": "Li D.W., Sun J.Y., Wang K., Zhang S., Hou Y.J., Yang M.F., Fu X.Y., Zhang Z.Y., Mao L.L., Yuan H., et al. Attenuation of Cisplatin-Induced Neurotoxicity by Cyanidin, a Natural Inhibitor of ROS-Mediated Apoptosis in PC12 Cells. Cell. Mol. Neurobiol. 2015;35:995\u20131001. doi: 10.1007/s10571-015-0194-6.", "ArticleIdList": ["10.1007/s10571-015-0194-6", "25895624"]}, {"Citation": "\u00dcst\u00fcn R., O\u011fuz E.K., \u015eeker A., Korkaya H. Thymoquinone prevents cisplatin neurotoxicity in primary DRG neurons. Neurotoxicology. 2018;69:68\u201376. doi: 10.1016/j.neuro.2018.09.001.", "ArticleIdList": ["10.1016/j.neuro.2018.09.001", "30227172"]}, {"Citation": "Kandeil M.A., Mahmoud M.O., Abdel-Razik A.R.H., Gomaa S.B. Thymoquinone and geraniol alleviate cisplatin-induced neurotoxicity in rats through downregulating the p38 MAPK/STAT-1 pathway and oxidative stress. Life Sci. 2019;228:145\u2013151. doi: 10.1016/j.lfs.2019.04.065.", "ArticleIdList": ["10.1016/j.lfs.2019.04.065", "31047895"]}, {"Citation": "Chen C., Zhang H., Xu H., Zheng Y., Wu T., Lian Y. Ginsenoside Rb1 ameliorates cisplatin-induced learning and memory impairments. J. Ginseng Res. 2019;43:499\u2013507. doi: 10.1016/j.jgr.2017.07.009.", "ArticleIdList": ["10.1016/j.jgr.2017.07.009", "PMC6823748", "31695559"]}, {"Citation": "Di Cesare Mannelli L., Lucarini E., Micheli L., Mosca I., Ambrosino P., Soldovieri M.V., Martelli A., Testai L., Taglialatela M., Calderone V., et al. Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels. Neuropharmacology. 2017;121:49\u201359. doi: 10.1016/j.neuropharm.2017.04.029.", "ArticleIdList": ["10.1016/j.neuropharm.2017.04.029", "28431970"]}, {"Citation": "Lucarini E., Micheli L., Trallori E., Citi V., Martelli A., Testai L., De Nicola G.R., Iori R., Calderone V., Ghelardini C., et al. Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2S release in vivo. Phyther. Res. 2018;32:2226\u20132234. doi: 10.1002/ptr.6159.", "ArticleIdList": ["10.1002/ptr.6159", "30069944"]}, {"Citation": "Di Cesare Mannelli L., Zanardelli M., Failli P., Ghelardini C. Oxaliplatin-induced neuropathy: Oxidative Stress as Pathological Mechanism. Protective Effect of Silibinin. J. Pain. 2012;13:276\u2013284. doi: 10.1016/j.jpain.2011.11.009.", "ArticleIdList": ["10.1016/j.jpain.2011.11.009", "22325298"]}, {"Citation": "Kumburovic I., Selakovic D., Juric T., Jovicic N., Mihailovic V., Stankovic J.K., Sreckovic N., Kumburovic D., Jakovljevic V., Rosic G. Antioxidant Effects of Satureja hortensis L. Attenuate the Anxiogenic Effect of Cisplatin in Rats. Oxid. Med. Cell. Longev. 2019;2019:8307196. doi: 10.1155/2019/8307196.", "ArticleIdList": ["10.1155/2019/8307196", "PMC6701305", "31467638"]}, {"Citation": "Ushio S., Egashira N., Sada H., Kawashiri T., Shirahama M., Masuguchi K., Oishi R. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents. Eur. J. Cancer. 2012;48:1407\u20131413. doi: 10.1016/j.ejca.2011.08.009.", "ArticleIdList": ["10.1016/j.ejca.2011.08.009", "21907570"]}, {"Citation": "Nishioka M., Shimada M., Kurita N., Iwata T., Morimoto S., Yoshikawa K., Higashijima J., Miyatani T., Kono T. The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen. Int. J. Clin. Oncol. 2011;16:322\u2013327. doi: 10.1007/s10147-010-0183-1.", "ArticleIdList": ["10.1007/s10147-010-0183-1", "21258836"]}, {"Citation": "Kono T., Hata T., Morita S., Munemoto Y., Matsui T., Kojima H., Takemoto H., Fukunaga M., Nagata N., Shimada M., et al. Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): A phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy. Cancer Chemother. Pharmacol. 2013;72:1283\u20131290. doi: 10.1007/s00280-013-2306-7.", "ArticleIdList": ["10.1007/s00280-013-2306-7", "PMC3834178", "24121454"]}, {"Citation": "Wei X., Zhu L., Wang H., Wang C., Deng Q., Li X. Efficacy of Traditional Chinese Medicines in Preventing Oxaliplatin-induced Peripheral Neurotoxicity in Cancer Patients: A Network Meta-analysis. Chin. Herb. Med. 2017;9:161\u2013168. doi: 10.1016/S1674-6384(17)60090-X.", "ArticleIdList": ["10.1016/S1674-6384(17)60090-X"]}, {"Citation": "Di Cesare Mannelli L., Zanardelli M., Bartolucci G., Karioti A., Bilia A.R., Vannacci A., Mugelli A., Ghelardini C. In Vitro Evidence for the Use of Astragali Radix Extracts as Adjuvant against Oxaliplatin-Induced Neurotoxicity. Planta Med. 2015;81:1045\u20131055. doi: 10.1055/s-0035-1546117.", "ArticleIdList": ["10.1055/s-0035-1546117", "26039263"]}, {"Citation": "Di Cesare Mannelli L., Piccolo M., Maione F., Ferraro M.G., Irace C., De Feo V., Ghelardini C., Mascolo N. Tanshinones from Salvia miltiorrhiza Bunge revert chemotherapy-induced neuropathic pain and reduce glioblastoma cells malignancy. Biomed. Pharmacother. 2018;105:1042\u20131049. doi: 10.1016/j.biopha.2018.06.047.", "ArticleIdList": ["10.1016/j.biopha.2018.06.047", "30021339"]}, {"Citation": "Abad A.N.A., Nouri M.H.K., Gharjanie A., Tavakoli F. Effect of Matricaria chamomilla Hydroalcoholic Extract on Cisplatin-induced Neuropathy in Mice. Chin. J. Nat. Med. 2011;9:126\u2013131. doi: 10.3724/SP.J.1009.2011.00126.", "ArticleIdList": ["10.3724/SP.J.1009.2011.00126"]}, {"Citation": "Cinci L., Di Cesare Mannelli L., Maidecchi A., Mattoli L., Ghelardini C. Effects of Hypericum perforatum extract on oxaliplatin-induced neurotoxicity: In vitro evaluations. Z. Naturforsch. C. 2017;72:219\u2013226. doi: 10.1515/znc-2016-0194.", "ArticleIdList": ["10.1515/znc-2016-0194", "28160544"]}, {"Citation": "Micheli L., Mattoli L., Maidecchi A., Pacini A., Ghelardini C., Di Cesare Mannelli L. Effect of Vitis vinifera hydroalcoholic extract against oxaliplatin neurotoxicity: In vitro and in vivo evidence. Sci. Rep. 2018;8:1\u201314. doi: 10.1038/s41598-018-32691-w.", "ArticleIdList": ["10.1038/s41598-018-32691-w", "PMC6156221", "30254294"]}, {"Citation": "Yousef M.I., Khalil D.K.A.M., Abdou H.M. Neuro- and nephroprotective effect of grape seed proanthocyanidin extract against carboplatin and thalidomide through modulation of inflammation, tumor suppressor protein p53, neurotransmitters, oxidative stress and histology. Toxicol. Rep. 2018;5:568\u2013578. doi: 10.1016/j.toxrep.2018.04.006.", "ArticleIdList": ["10.1016/j.toxrep.2018.04.006", "PMC5978013", "29854627"]}, {"Citation": "Lee J.S., Kim Y.T., Jeon E.K., Won H.S., Cho Y.S., Ko Y.H. Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats. BMC Complement. Altern. Med. 2012;12:1. doi: 10.1186/1472-6882-12-124.", "ArticleIdList": ["10.1186/1472-6882-12-124", "PMC3476978", "22894541"]}, {"Citation": "Cho E.S., Yi J.M., Park J.S., Lee Y.J., Lim C.J., Bang O.S., Kim N.S. Aqueous extract of Lithospermi radix attenuates oxaliplatin-induced neurotoxicity in both in vitro and in vivo models. BMC Complement. Altern. Med. 2016;16 doi: 10.1186/s12906-016-1396-2.", "ArticleIdList": ["10.1186/s12906-016-1396-2", "PMC5080763", "27782842"]}, {"Citation": "Fraga C.G., Croft K.D., Kennedy D.O., Tom\u00e1s-Barber\u00e1n F.A. The effects of polyphenols and other bioactives on human health. Food Funct. 2019;10:514\u2013528. doi: 10.1039/C8FO01997E.", "ArticleIdList": ["10.1039/C8FO01997E", "30746536"]}, {"Citation": "Del Rio D., Rodriguez-Mateos A., Spencer J.P.E., Tognolini M., Borges G., Crozier A. Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases. Antioxid. Redox Signal. 2013;18:1818\u20131892. doi: 10.1089/ars.2012.4581.", "ArticleIdList": ["10.1089/ars.2012.4581", "PMC3619154", "22794138"]}, {"Citation": "Heleno S.A., Martins A., Queiroz M.J.R.P., Ferreira I.C.F.R. Bioactivity of phenolic acids: Metabolites versus parent compounds: A review. Food Chem. 2015;173:501\u2013513. doi: 10.1016/j.foodchem.2014.10.057.", "ArticleIdList": ["10.1016/j.foodchem.2014.10.057", "25466052"]}, {"Citation": "Szwajgier D., Borowiec K., Pustelniak K. The neuroprotective effects of phenolic acids: Molecular mechanism of action. Nutrients. 2017;9:477. doi: 10.3390/nu9050477.", "ArticleIdList": ["10.3390/nu9050477", "PMC5452207", "28489058"]}, {"Citation": "Domitrovi\u0107 R., Poto\u010dnjak I., Crn\u010devi\u0107-Orli\u0107 \u017d., \u0160koda M. Nephroprotective activities of rosmarinic acid against cisplatin-induced kidney injury in mice. Food Chem. Toxicol. 2014;66:321\u2013328. doi: 10.1016/j.fct.2014.02.002.", "ArticleIdList": ["10.1016/j.fct.2014.02.002", "24518541"]}, {"Citation": "Y\u00fcce A., Ate\u015f\u015fahin A., Ceriba\u015fi A.O., Aksakal M. Ellagic acid prevents cisplatin-induced oxidative stress in liver and heart tissue of rats. Basic Clin. Pharmacol. Toxicol. 2007;101:345\u2013349. doi: 10.1111/j.1742-7843.2007.00129.x.", "ArticleIdList": ["10.1111/j.1742-7843.2007.00129.x", "17910619"]}, {"Citation": "Yamabe N., Park J.Y., Lee S.S., Cho E.-J.J., Lee S.S., Kang K.S., Hwang G.S., Kim S.-N.N., Kim H.Y., Shibamoto T. Protective effects of protocatechuic acid against cisplatin-induced renal damage in rats. J. Funct. Foods. 2015;19:20\u201327. doi: 10.1016/j.jff.2015.08.028.", "ArticleIdList": ["10.1016/j.jff.2015.08.028"]}, {"Citation": "Chirino Y.I., Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp. Toxicol. Pathol. 2009;61:223\u2013242. doi: 10.1016/j.etp.2008.09.003.", "ArticleIdList": ["10.1016/j.etp.2008.09.003", "18986801"]}, {"Citation": "Figueiredo S., Filho S., Nogueira-Machado J., Caligiorne R. The Anti-Oxidant Properties of Isothiocyanates: A Review. Recent Pat. Endocr. Metab. Immune Drug Discov. 2013;7:213\u2013225. doi: 10.2174/18722148113079990011.", "ArticleIdList": ["10.2174/18722148113079990011", "23978168"]}, {"Citation": "Lorenzo J.M., Putnik P., Bursa\u0107 Kova\u010devi\u0107 D., Petrovi\u0107 M., Munekata P.E., G\u00f3mez B., Marsza\u0142ek K., Roohinejad S., Barba F.J. Studies in Natural Products Chemistry. Elsevier; Amsterdam, The Netherlands: 2020. Silymarin compounds: Chemistry, innovative extraction techniques and synthesis; pp. 111\u2013130."}, {"Citation": "Xu J., Wei K., Zhang G., Lei L., Yang D., Wang W., Han Q., Xia Y., Bi Y., Yang M., et al. Ethnopharmacology, phytochemistry, and pharmacology of Chinese Salvia species: A review. J. Ethnopharmacol. 2018;225:18\u201330. doi: 10.1016/j.jep.2018.06.029.", "ArticleIdList": ["10.1016/j.jep.2018.06.029", "29935346"]}, {"Citation": "Silva B.A., Ferreres F., Malva J.O., Dias A.C.P. Phytochemical and antioxidant characterization of Hypericum perforatum alcoholic extracts. Food Chem. 2005;90:157\u2013167. doi: 10.1016/j.foodchem.2004.03.049.", "ArticleIdList": ["10.1016/j.foodchem.2004.03.049"]}, {"Citation": "Oliveira A.I., Pinho C., Sarmento B., Dias A.C.P. Neuroprotective Activity of Hypericum perforatum and Its Major Components. Front. Plant Sci. 2016;7 doi: 10.3389/fpls.2016.01004.", "ArticleIdList": ["10.3389/fpls.2016.01004", "PMC4939296", "27462333"]}, {"Citation": "Huang N., Rizshsky L., Hauck C., Nikolau B.J., Murphy P.A., Birt D.F. Identification of anti-inflammatory constituents in Hypericum perforatum and Hypericum gentianoides extracts using RAW 264.7 mouse macrophages. Phytochemistry. 2011;72:2015\u20132023. doi: 10.1016/j.phytochem.2011.07.016.", "ArticleIdList": ["10.1016/j.phytochem.2011.07.016", "PMC3197739", "21855951"]}, {"Citation": "Rameshrad M., Razavi B.M., Hosseinzadeh H. Protective effects of green tea and its main constituents against natural and chemical toxins: A comprehensive review. Food Chem. Toxicol. 2017;100:115\u2013137. doi: 10.1016/j.fct.2016.11.035.", "ArticleIdList": ["10.1016/j.fct.2016.11.035", "27915048"]}]}], "History": [{"Year": "2020", "Month": "8", "Day": "29"}, {"Year": "2020", "Month": "10", "Day": "10"}, {"Year": "2020", "Month": "10", "Day": "16"}, {"Year": "2020", "Month": "10", "Day": "23", "Hour": "1", "Minute": "1"}, {"Year": "2020", "Month": "10", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["33092125", "PMC7589133", "10.3390/ijms21207753", "ijms21207753"]}}]}